Orencia and Rhinitis - a phase IV clinical study of FDA data

Summary:

Rhinitis is reported as a side effect among people who take Orencia (abatacept), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Arava, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Rhinitis when taking Orencia. It is created by eHealthMe based on reports of 135,080 people who have side effects when taking Orencia from the FDA, and is updated regularly.

What is Orencia?

Orencia has active ingredients of abatacept. It is often used in rheumatoid arthritis. eHealthMe is studying from 135,415 Orencia users. Check the latest studies of Orencia.

What is Rhinitis?

Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose) is found to be associated with 977 drugs and 968 conditions by eHealthMe. Check the latest studies of Rhinitis.

On Aug, 05, 2026

135,080 people reported to have side effects when taking Orencia.
Among them, 55 people (0.04%) have Rhinitis.

Among these 55 people:

How long have people been on Orencia when they have Rhinitis? *

What is the gender of people who have Rhinitis when taking Orencia? *

female: 92.16 %
male: 7.84 %

What is the age of people who have Rhinitis when taking Orencia? *

What are other drugs people take besides Orencia? *

Arava: 14 people, 25.45%
Acetaminophen: 11 people, 20.00%
Simponi: 11 people, 20.00%
Methylprednisolone: 9 people, 16.36%
Oxycodone Hydrochloride: 9 people, 16.36%
Methylprednisolone Sodium Succinate: 9 people, 16.36%
Risedronate Sodium: 9 people, 16.36%
Tylenol: 9 people, 16.36%
Leflunomide: 9 people, 16.36%
Benadryl: 8 people, 14.55%

What are other side effects people have besides Rhinitis? *

Pain: 16 people, 29.09%
Drug Ineffective: 15 people, 27.27%
Mobility Decreased (ability to move is reduced): 13 people, 23.64%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 13 people, 23.64%
Nasopharyngitis (inflammation of the nasopharynx): 12 people, 21.82%
Infusion Related Reaction: 11 people, 20.00%
Sinusitis (inflammation of sinus): 11 people, 20.00%
Weakness: 10 people, 18.18%
Arthropathy: 10 people, 18.18%
Fever: 10 people, 18.18%

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 7.27%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.45%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 3.64%
Immunodeficiency: 2 people, 3.64%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 3.64%
Depression: 2 people, 3.64%
Pathological Fracture (broken bone caused by disease): 1 person, 1.82%
Osteoporosis (bones weak and more likely to break): 1 person, 1.82%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 1.82%
Insomnia (sleeplessness): 1 person, 1.82%

* Approximation only. Some reports may have incomplete information.

Do you take Orencia and have Rhinitis?

- Check whether Rhinitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Orencia:

Orencia (135,415 reports)

Rhinitis treatments and more:

Rhinitis (15,448 reports)

Browse all side effects of Orencia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rhinitis:

Rhinitis (977 drugs)

Browse all the conditions that are associated with Rhinitis:

Rhinitis (968 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abatacept (the active ingredients of Orencia) and Orencia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.